Now more than ever, pharmaceutical brand managers are facing increased pressure to achieve aggressive revenue targets with tighter budgets and increased ROI scrutiny. With fewer blockbusters on the horizon, pharma marketers must optimize performance of each product.

That’s why one major manufacturer asked MSI to track its product, a drug that treats depression and anxiety. We came up with a system that continuously updates every entry in the category, monitoring each drug’s position among key physician segments, PCPs and psychiatrists. Our client receives regular snapshots of the market, including measures of product/advertising awareness, physician attitudes, prescription behavior, and brand profiles.

Our work has helped the client maintain market share throughout the product’s lifecycle, enabling them to fine-tune the allocation of promotional and advertising expenses and achieve the best sales channel mix for maximum profitability.